Literature DB >> 21255574

Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.

Ann D Kwong1, Isabel Najera, Jill Bechtel, Scott Bowden, Joseph Fitzgibbon, Patrick Harrington, Dale Kempf, Tara L Kieffer, Diana Koletzki, George Kukolj, Sharlene Lim, Tami Pilot-Matias, Kai Lin, Nina Mani, Hongmei Mo, Jules O'Rear, Michael Otto, Neil Parkin, Jean-Michel Pawlotsky, Chris Petropoulos, Gaston Picchio, Robert Ralston, Jacqueline D Reeves, Robert T Schooley, Scott Seiwert, David Standring, Lieven Stuyver, James Sullivan, Veronica Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21255574     DOI： 10.1053/j.gastro.2011.01.029

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Virologic escape during danoprevir (ITMN-191/RG7227) monotherapy is hepatitis C virus subtype dependent and associated with R155K substitution.

Authors:  Sharlene R Lim; Xiaoli Qin; Simone Susser; John B Nicholas; Christian Lange; Eva Herrmann; Jin Hong; Ann Arfsten; Lisa Hooi; Williamson Bradford; Isabel Nájera; Patrick Smith; Stefan Zeuzem; Karl Kossen; Christophe Sarrazin; Scott D Seiwert
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 3.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

4.  Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.

Authors:  Kristi L Berger; Lisette Lagacé; Ibtissem Triki; Mireille Cartier; Martin Marquis; Carol Lawetz; Richard Bethell; Joseph Scherer; George Kukolj
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

5.  Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.

Authors:  Celia Perales; Nathan M Beach; Isabel Gallego; Maria Eugenia Soria; Josep Quer; Juan Ignacio Esteban; Charles Rice; Esteban Domingo; Julie Sheldon
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

6.  Ultra-deep pyrosequencing (UDPS) data treatment to study amplicon HCV minor variants.

Authors:  Josep Gregori; Juan I Esteban; María Cubero; Damir Garcia-Cehic; Celia Perales; Rosario Casillas; Miguel Alvarez-Tejado; Francisco Rodríguez-Frías; Jaume Guardia; Esteban Domingo; Josep Quer
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 7.  Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology).

Authors:  C Torti; M Zazzi; L Abenavoli; F Trapasso; F Cesario; D Corigliano; L Cosco; C Costa; R L Curia; M De Rosa; G Foti; C Giraldi; R Leone; M C Liberto; D Lucchino; N Marascio; R Masciari; G Matera; V Pisani; N Serrao; L Surace; E Zicca; F Castelli; M Ciccozzi; M Puoti; A Focà
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

8.  Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples.

Authors:  Eileen Z Zhang; Doug J Bartels; J Dan Frantz; Sheila Seepersaud; Judith A Lippke; Benjamin Shames; Yi Zhou; Chao Lin; Ann Kwong; Tara L Kieffer
Journal:  Virol J       Date:  2013-02-12       Impact factor: 4.099

9.  Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms.

Authors:  Yuri S Fantin; Alexey D Neverov; Alexander V Favorov; Maria V Alvarez-Figueroa; Svetlana I Braslavskaya; Maria A Gordukova; Inga V Karandashova; Konstantin V Kuleshov; Anna I Myznikova; Maya S Polishchuk; Denis A Reshetov; Yana A Voiciehovskaya; Andrei A Mironov; Vladimir P Chulanov
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

10.  Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis.

Authors:  Ana M Ortega-Prieto; Julie Sheldon; Ana Grande-Pérez; Héctor Tejero; Josep Gregori; Josep Quer; Juan I Esteban; Esteban Domingo; Celia Perales
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.